-- 澳大利亚临床实验室（ASX：ACL）周四向澳大利亚证券交易所提交的文件显示，该公司旗下子公司SunDoctors使用的一家外部IT服务提供商近期遭遇网络安全事件，未经授权的第三方访问了该部门的部分系统。 SunDoctors已控制住此次事件，该事件仅对公司运营造成了短暂影响，目前所有系统均已恢复正常。公司正在调查此次事件，以确定是否有任何敏感个人信息泄露。 澳大利亚临床实验室表示，此次事件未对其自身核心实验室系统或运营造成任何影响。 该公司股价在周四的交易中下跌了1%。
Related Articles
Asia
Xinhua Winshare Publishing and Media's Profit Slips 1% in Q1
Xinhua Winshare Publishing and Media (HKG:0811, SHA:601811) posted net profit attributable to shareholders of 257.2 million yuan in the first quarter, down 1% from 259.9 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the publisher were down over 1% in Thursday's late morning trade.Earnings per share stood at 0.21 yuan, unchanged from a year earlier.Operating income was little changed at 2.48 billion yuan, compared with 2.49 billion yuan in the prior-year period.
$HKG:0811$SHA:601811
Asia
Beijing SinoHytec's Q1 Loss Narrows
Beijing SinoHytec (HKG:2402, SHA:688339) recorded 51 million yuan in attributable loss in the first quarter, narrowing from 93 million yuan a year prior, according to a Hong Kong bourse filing Thursday.Loss per share was 0.21 yuan, compared with 0.40 yuan a year earlier.Operating income rose 58% year on year to 16.7 million yuan, figures showed.
$HKG:2402$SHA:688339
Asia
Immutep Receives Nasdaq Non-Compliance Notice Over Minimum Bid Price Requirement; Shares Fall 8% in Australia
Immutep (ASX:IMM) received a notification from Nasdaq for not complying with the minimum bid price requirement for continued share listing, according to a Thursday Australian bourse filing.The closing bid price of the company's American depositary shares (ADS) failed to meet the $1-per-share minimum for 30 consecutive business days ended April 24, per the notification.The company said the notification has no immediate effect on the listing or trading of its ADSs, as Nasdaq has provided an initial compliance period of 180 calendar days expiring on Oct. 26 to regain compliance.Compliance can be regained if the closing bid price of the ADSs is at least $1 per share for a minimum of 10 consecutive business days during the compliance period, the filing added.The company said it intends to monitor the bid price and consider available options, noting that there can be no assurance that compliance will be regained.The company's Nasdaq-listed shares were last trading at $0.48 and have fallen more than 72% over the last 12 months.The company's Australian shares were down nearly 8% in recent Thursday trade.
$ASX:IMM